Chapman Gina — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Chapman Gina has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Gina Chapman is identified in SEC filings as a director of Entrada Therapeutics, Inc. as of the most recent filing date (June 12, 2026). The available context provides only this board role and does not reveal additional biographical details or career history. Therefore, the biography based on the SEC context is limited to her position as a director at Entrada Therapeutics.

Board memberships

• Entrada Therapeutics, Inc.

Awards & honors

• Public board director of Entrada Therapeutics, Inc. (as of 2026-06-12)

Companies — Last 90 Days

• Entrada Therapeutics, Inc. (TRDA) — 1 filings, last 2026-06-12

Frequently Asked Questions

Who is Chapman Gina?

Gina Chapman is identified in SEC filings as a director of Entrada Therapeutics, Inc. as of the most recent filing date (June 12, 2026). The available context provides only this board role and does not reveal additional biographical details or career history. Therefore, the biography based on the SEC context is limited to her position as a director at Entrada Therapeutics.…

How many SEC Form 4 filings has Chapman Gina submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Chapman Gina's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week